We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Applied Biosystems Completes Equity Investment in VisiGen

News   Dec 12, 2005

 
Applied Biosystems Completes Equity Investment in VisiGen
 
 
 

RELATED ARTICLES

Human Cell Atlas Study Sheds Light on Maternal-Fetal Interface

News

The first Human Cell Atlas study of early pregnancy in humans has shown how the function of the maternal immune system is affected by cells from the developing placenta.

READ MORE

Sequencing Offers New Hope for Rare Cancers

News

A cancer’s genetic sequence may be the key to matching people with rare cancers to the right anti-cancer treatments, according to a new clinical trial instigated by patients.

READ MORE

Synthetic Molecule Invades Double-stranded DNA

News

Researchers have developed a synthetic molecule that can recognize and bind to double-stranded DNA or RNA under normal physiological conditions. The molecule could provide a new platform for developing methods for the diagnosis and treatment of genetic conditions.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE